Vontobel Holding Ltd. Sangamo Therapeutics, Inc Transaction History
Vontobel Holding Ltd.
- $27.3 Billion
- Q4 2024
A detailed history of Vontobel Holding Ltd. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Vontobel Holding Ltd. holds 152,100 shares of SGMO stock, worth $177,957. This represents 0.0% of its overall portfolio holdings.
Number of Shares
152,100
Previous 300,000
49.3%
Holding current value
$177,957
Previous $258,000
39.92%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding SGMO
# of Institutions
118Shares Held
43.8MCall Options Held
576KPut Options Held
1.17M-
Vanguard Group Inc Valley Forge, PA9.37MShares$11 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT9.23MShares$10.8 Million0.05% of portfolio
-
State Street Corp Boston, MA5.02MShares$5.87 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$5.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.08MShares$3.61 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $183M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...